Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome
β Scribed by T. Tings; G. Stiens; W. Paulus; C. Trenkwalder; S. Happe
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 134 KB
- Volume
- 252
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The restless legs syndrome (RLS) is a common neurological disorder of sleep/wake motor regulation that is associated with sleep disturbances. Here, we review the evidence that RLS is also associated with increased daytime sleepiness. Summarizing 26 studies that assessed sleepiness by means of the Ep
## Abstract Although dopamine agonists are becoming firstβline therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here, 150 RLS patients who had responded to pramipexole during a 6βmonth runβin period (mean dose, 0.50 mg) were randomly assigned to r